Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its complete financial results...
Biotechnology firm Quanterix has taken a pivotal step toward transforming the diagnosis of Alzheimer's disease. The company has formally submitted...
Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC platform for rare...
The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which concluded in late...
Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business line and finalizes...
Medical device company Embecta reported financial results for the first quarter of fiscal year 2026 on Thursday, delivering revenue and...
Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The biopharmaceutical firm is...
The year 2026 is shaping up to be a critical period for Vir Biotechnology, with a series of scheduled clinical...
Coherus BioSciences has secured a significant partnership for its clinical development efforts, aligning with Janssen Research & Development, a Johnson...
Akso Health Group has solidified its strategic shift into the healthcare industry with the launch of a major global program...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com